International guidelines

Rest of the world

NCCN clinical practice guidelines in oncology: myeloproliferative neoplasms[26]

Published by:National Comprehensive Cancer Network

Last published:2025

NCCN clinical practice guidelines in oncology: hematopoietic cell transplantation (HCT)[92]

Published by:National Comprehensive Cancer Network

Last published:2025

Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working Group[50]

Published by:European Society for Blood and Marrow Transplantation/European LeukemiaNet

Last published:2023

Diagnosis and evaluation of prognosis myelofibrosis: a British Society for Haematology guideline[39]

Published by:British Society for Haematology

Last published:2023

The management of myelofibrosis: a British Society for Haematology guideline​​[51]

Published by:British Society for Haematology

Last published:2023

The use of genetic tests to diagnose and manage patients with myeloproliferative and myeloproliferative/myelodysplastic neoplasms, and related disorders[43]

Published by:British Society for Haematology

Last published:2021

Philadelphia chromosome-negative chronic myeloproliferative neoplasms: ESMO clinical practice guidelines for diagnosis, treatment and follow-up[42]

Published by:European Society for Medical Oncology

Last published:2015

Use of this content is subject to our disclaimer